Sign inJoin waitlistJoin the waitlist

SG

Sarah Gordon

Medical Director, Bodine Infusion · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · · ·

History

Bodine Infusion · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
Sidney Kimmel Comprehensive Cancer Center · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present

Hematology and Medical Oncology
Virginia Commonwealth University School of Medicine
2016–2019
Drexel University College of Medicine/Hahnemann University
2013–2016
Philadelphia College of Osteopathic Medicine
2005–2009

Research

Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity
Case report · The American Journal of Surgical Pathology · 2018 · 91 citations
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models
Scientific Reports · 2019 · 47 citations
PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide
Oncotarget · 2017 · 42 citations

AP
Andrew Poklepovic
5 papers
CA
Carol Aghajanian
3 papers
Kathleen Moore
3 papers
ST
Sarah Temkin
3 papers
WM
William Mcguire
3 papers
Andrea Hagemann
2 papers
CM
Cara Mathews
2 papers
Danielle Shafer
2 papers
Deborah Armstrong
2 papers
GW
Gregory Whitehorn
2 papers · 1 as a resident
Heidi Gray
2 papers
Joan Walker
2 papers

Clinical trials

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2031